A biotech startup leads a new effort to edit human embryos therapeutically, hoping technical advances will persuade ...
Editas Medicine (EDIT) traded higher on Thursday after Australian authorities cleared a Phase 1/2 trial for the company’s gene-editing therapy EDIT-401, and Wells Fargo upgraded the biotech to ...
A digital fruit fly brain quickly became an AI meme machine. It raises tough questions: could machines become conscious, and ...
Epigenetics has spent the past two decades promising to rewrite the rules of biology. The idea that chemical tags sitting on top of DNA can switch genes on and off, that these tags can be shaped by ...
Antimicrobial resistance is a major global health threat, with disproportionate impact in regions with limited diagnostic ...
AI company Anthropic announced last week that its flagship model Claude had identified a new type of enzyme. But a researcher ...
Boost ROI by aligning models with clinical goals, standardizing validation and data, using auditable AI, improving reproducibility and welfare, and adopting organoid and computational ...
Forbes contributors publish independent expert analyses and insights. Sai writes about healthcare, innovation and technology. This voice experience is generated by AI. Learn more. This voice ...
Skybound Entertainment will reveal new comics at New York Comic Con on October 9 -- and Terminal, Robert Kirkman’s superhero series, has independently reconstructed the biological architecture of ...
The pioneers of the CRISPR gene-editing tool won a Nobel prize in 2020, and for good reason. The breakthrough has revolutionised biology, and is also transforming medicine and farming. Now, AI company ...
Researchers used CRISPR to remove CD33 from donor stem cells, potentially giving doctors a way to attack aggressive blood cancers without destroying the healthy cells patients need after a transplant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results